NewslettersCancer Stem Cell NewsOrganoid NewsPancreatic Cell News Activation of the PI3K/AKT Signaling Pathway by ARNTL2 Enhances Cellular Glycolysis and Sensitizes Pancreatic Adenocarcinoma to Erlotinib By Noshin Noorjahan - March 15, 2024 0 Investigators examined the levels of various cancer hallmarks and identified glycolysis as the primary risk factor for overall survival in pancreatic cancer. [Molecular Cancer] Full Article